Cover Stars!
Landmark literature, global impacts, ophthalmology of the near future, and Rising Stars… We look back on The Ophthalmologist's 2023 magazine covers
Alun Evans | | 5 min read | Review
Who isn’t a fan of books? The beginning of 2023 saw The Ophthalmologist looking back at the year just gone, featuring experts from the ophthalmology community who shared with us the landmark literature and research that had stood out for them in 2022. A thematic thread running through the issue is everything “new” in the world of ophthalmology, with “Peptide Pioneer,” Robert Yu, discussing his new peptide treatment for dry eye disease; a review of a new tomography device – STOC-T – capable of changing the scope for retinal and choroidal imaging; and researchers linking a newly discovered mutation in the THBS1 gene to congenital glaucoma.
For our 100th issue, our 2023 Power List celebrates 100 individuals whose excellence over the last 10 years have shaped the field. The theme is the bold-sounding “Ten Years of Excellence and Impact in Ophthalmology,” covered in our editorial, The Power of One. Speaking of the Power List, did you know that we are now accepting nominations for 2024? Click here to nominate someone you think is deserving of the recognition (nominations are open until January 31, 2024).
Also in this issue: David Peprah discusses how institutions must do more to tackle systemic racism within healthcare and we interview Himal Kandel on “The Joy of Exploration.”
Check out the beautiful contrast of the yellows and pinks in this powered-up cover! In this issue, we focus on how European eye care experts are reacting to globally rising myopia rates, Jasleen Jolly argues for the importance of cross-disciplinary collaboration for research and practice in ophthalmology, and Harvard Medical School’s Nandini Venkateswaran offers advice on how to find the best artificial tears for dry eye disease.
A beautiful watercolor painting adorns the cover of our July/August issue. The Art of Eyes, a curation of artwork by both ophthalmologists and visually impaired artists was compiled by our associate editor, Sarah Healey. The issue also features our ten very first inductees into our newly minted Power List Hall of Fame, our way of honoring some of the giants in the field whose contributions have been truly transformative.
Also in this issue: Jennifer Jacobs discusses a teleophthalmology model that could revolutionize AMD monitoring and treatment, and there’s an interview with ophthalmologist and award-winning author, Andrew Lam.
In this dynamic issue, we profile some of the major institutions involved in advancing ophthalmology training throughout the world. From Mexico to India, these are some of the global institutions really going that extra mile to address the widespread unmet needs and regional gaps in ophthalmic training. Our September/October issue also introduces our first ever Rising Stars, a specially selected (each candidate was nominated by one or more Power List alumni) group of individuals, who we believe show great professional promise for the years ahead.
Also in this issue: validating geographic atrophy treatment with deep learning, how genetic coding could aid glaucoma management, and sitting down with Rajesh Rajpal, Chief Medical Officer at Johnson & Johnson Vision.
Our December feature, Ophthalmology of the Near Future, covers a range of exciting future-looking topics, from the potential wonders of nanotechnology for ocular drug delivery, to the retinal and neural implant market, to advances in VR Visions, 3D Printing, and ocular regenerative therapies. The (near) future certainly looks promising for ophthalmology!
Also in this issue: one of our 2023 Rising Stars, Arjan Hura, discusses what he thinks may be in store for the future of refractive surgery, we look at a new development that could herald an important next step in the future of smart contact lenses, and we feature an interview with Sascha Fauser, Global Head of Ophthalmology, Pharma Research and Early Development at Roche.